Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 September 2021 | Story Lacea Loader

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State (UFS), will answer questions about the COVID-19 vaccine and its affects.  

The webinar will address questions such as the following:

• what vaccination is and how it works
• how vaccines are developed and how we know they are safe and effective
• how the COVID-19 vaccine works and how it can protect you
• the side effects of the vaccine
• the risks vs benefits of the vaccine.

You can also forward questions prior to the webinar to grimbeekl@ufs.ac.za

Date: Friday 10 September 2021
Time: 11:00-12:00
Register for the webinar


News Archive

UFS to act as agent for Cipal in Southern Africa
2006-03-12

The University of the Free State signed an agreement with Cipal, a Belgium software development company, to act as agent for Cipal in Southern Africa.

The university already utilises the Parnassus software from Cipal under licence since 2004 for among others meetings, compiling the annual report to the Minister of Education and compiling the UFS annual institutional calendar. Four faculties at the UFS also use Cipal products.  The university will market this initiative to other universities as an entrepreneurial project to generate income for the UFS.

At the signing of an agreement were from the left (standing) Prof Sakkie Steyn (Registrar: General at the UFS, Prof Frederick Fourie ( Rector and Vice-Chancellor of the UFS), Mr Leo Stevens (Chairperson of the Cipal Management Council and Board) and Mr Arthur Phillips (Director-General and Chief Executive Officer of Cipal).
Photo:  Leonie Bolleurs

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept